Insiders · Profile

Geffken Daniel E.

INTERIM CFO at Eloxx Pharmaceuticals. Filing since 29 Nov 2021. CIK 0001314756

Company

Date

Role

Action

Shares

Amount

Of holding

ELOX Eloxx Pharmaceuticals, Inc.

29 Nov 2021

INTERIM CFO

Bought

50,000

$36.00K

opened

1 decision on file.